Jenburkt Pharmaceuticals Ltd Q1 FY2024-2025 Results: Summary

Revenue
₹33.94Cr
Net Profits
₹7.42Cr
Net Profit Margins
21.86%

Highlights

Revenue:

Jenburkt Pharmaceuticals Ltd’s revenue jumped 12.35% since last year same period to ₹33.94Cr in the Q1 2024-2025. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated -15.21% fall in its revenue since last 3-months.

Net Profits:

Jenburkt Pharmaceuticals Ltd’s net profit jumped 38.18% since last year same period to ₹7.42Cr in the Q1 2024-2025. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated -5.84% fall in its net profits since last 3-months.

Net Profit Margins:

Jenburkt Pharmaceuticals Ltd’s net profit margin jumped 22.99% since last year same period to 21.86% in the Q1 2024-2025. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated 11.06% jump in its net profit margins since last 3-months.

FAQs

The revenue for Jenburkt Pharmaceuticals Ltd in the Q1 results 2024 was ₹33.94Cr.

The net profit for Jenburkt Pharmaceuticals Ltd in the Q1 results 2024 was ₹7.42Cr.

The net profit margin for Jenburkt Pharmaceuticals Ltd in the Q1 results 2024 was 21.86%.

The revenue for Jenburkt Pharmaceuticals Ltd in the Q1 results 2023 was ₹30.21Cr.

The net profit for Jenburkt Pharmaceuticals Ltd in the Q1 results 2023 was ₹5.37Cr.

The net profit margin for Jenburkt Pharmaceuticals Ltd in the Q1 results 2023 was 17.78%.